49.974250, 8.117803
Boehringer Ingelheim
Ingelheim am Rhein, Germany
- Verified lead
- Hubertus von Baumbach
- Lead status
- STATUS: VERIFIED MARCH 2026
- Leadership verification
- Chairman of the Board of Managing Directors
- 2026 technical specialization
- Biopharmaceutical Production and Therapeutic Manufacturing
- Review cycle
- May 2026
- Full address
- Binger Straße 173, 55216 Ingelheim am Rhein, Germany
- Site coordinates
- 49.974250, 8.117803
- Editorial review
- Memel Biotech editorial review
- Official leadership source
- Official Boehringer Ingelheim leadership page confirming Hubertus von Baumbach.
- Editorial note
- Boehringer Ingelheim joins the verified German core through a current official leadership surface and annual-report production disclosure.
Biopharmaceutical Production and Therapeutic Manufacturing
GMP Manufacturing, Global Quality and Production Network
Boehringer Ingelheim joins the verified German core through a current official leadership surface and annual-report production disclosure.
Boehringer Ingelheim
Biopharmaceutical Production and Therapeutic Manufacturing · Global therapeutic manufacturing
Verified 14 Mar 2026 · 3 sources
Boehringer Ingelheim joins the verified German core through a current official leadership surface and annual-report production disclosure.
- Website
- boehringer-ingelheim.com
- Company page
- Lead
- Hubertus von Baumbach (verified ↗)
- Compliance
- GMP Manufacturing
- Last reviewed
- 14 Mar 2026 (3mo ago)
- Scale
- Global therapeutic manufacturing
- Capabilities
- Biopharmaceutical Production · Small-Molecule Manufacturing · Global Fill-Finish and Supply Operations
- Founded
- 1885
- Headcount
- 10000+
Hubertus von Baumbach
Chairman of the Board of Managing Directors
Official Boehringer Ingelheim contact page listing Binger Straße 173, Ingelheim am Rhein.
Open sourceGlobal therapeutic manufacturing
Ingelheim am Rhein, Germany. Biopharmaceutical Production and Therapeutic Manufacturing. Review completed on 14 Mar 2026.
EMA, FDA, and German pharmaceutical oversight
GMP Manufacturing, Global Quality and Production Network
Biopharmaceutical Production and Therapeutic Manufacturing
Boehringer Ingelheim joins the verified German core through a current official leadership surface and annual-report production disclosure.
Boehringer Ingelheim joins the verified German core through a current official leadership surface and annual-report production disclosure.
Core capabilities
Primary declared technical activities and areas of operating focus.
Verification source dossier
Official source set used to support leadership, physical-site, certification, and watch-note evidence.
Declared infrastructure
Quality system coverage
GMP / GLP / ISO-13485 / FDA-Inspected are global quality-system standards. "Verified active" means the directory confirmed the certification is current; "Review in progress" means the cert status is currently being re-verified.
- GMP
- VERIFIED ACTIVE 2026
- GLP
- REVIEW IN PROGRESS 2026
- ISO-13485
- REVIEW IN PROGRESS 2026
- FDA-Inspected
- REVIEW IN PROGRESS 2026
Verification history
Frequently asked questions
- Where is Boehringer Ingelheim located?
- Boehringer Ingelheim operates from Binger Straße 173, 55216 Ingelheim am Rhein, Germany, Ingelheim am Rhein, Germany.
- Who runs Boehringer Ingelheim?
- Boehringer Ingelheim is led by Hubertus von Baumbach, Chairman of the Board of Managing Directors. Verified 14 Mar 2026.
- What certifications does Boehringer Ingelheim hold?
- Boehringer Ingelheim is documented under GMP Manufacturing.
- What does Boehringer Ingelheim do?
- Boehringer Ingelheim joins the verified German core through a current official leadership surface and annual-report production disclosure. Core capabilities: Biopharmaceutical Production, Small-Molecule Manufacturing, Global Fill-Finish and Supply Operations.
Related technical briefs
Briefs that name Ingelheim am Rhein as a covered market or city.
